9/23/2026
Clearmind expands U.S. patent portfolio with new applications
Patent applications cover novel combinations of LSD, ketamine, and ibogaine.
Topic archive
vancouver
3 stories
9/23/2026
Clearmind Medicine files US patents for psychedelic combinations
New patent applications aim to enhance mental health treatments using LSD, ketamine, ibogaine.
9/8/2026
Ibogaine and the bicameral mind book release highlights growing interest
Jonathan Dickinson's new book explores ibogaine's therapeutic potential amid rising U.S. policy focus.